Proton beam radiation therapy and the overall survival of adult and pediatric patients diagnosed with central nervous system tumors

质子束放射治疗与成人和儿童中枢神经系统肿瘤患者的总体生存率

阅读:3

Abstract

BACKGROUND: There is an increased interest in using proton beam radiation therapy (PBT) in Central nervous system (CNS) tumors. However, no clear information exists about the association of PBT with the overall survival (OS) of patients diagnosed with CNS tumors. The current study aims to investigate the association of PBT with the OS of patients with CNS tumors. METHODS: This study included patients from the National Cancer Database diagnosed with CNS tumors between 2004 and 2022. Multivariable Cox regression analysis was used to assess the OS. The multivariable analyses were adjusted for age at diagnosis, sex, race, RT dose, health insurance, histology, education, income, comorbidity score, surgery, chemotherapy, and year of diagnosis. RESULTS: Of the 162,506 patients, 5,548 (3.4%) received PBT. In the multivariable Cox regression analysis, patients who received PBT had longer OS compared to patients who received photon RT (Hazard Ratio (HR): 0.67 [95% CI: 0.64-0.71], p < 0.001). In the subset analyses stratified by surgery, the use of PBT was associated with improved OS compared to photon RT in patients who received surgery (HR:0.76 [95% CI: 0.70-0.82], p < 0.001) and in patients who did not receive surgery (HR: 0.61 [95% CI: 0.57-0.65], p < 0.001). When stratified by histology, PBT was associated with improved OS compared to photon RT in patients diagnosed with astrocytoma (HR: O.65 [95% CI: 0.53-0.81], p < 0.001), glioblastoma (HR: 0.79 [95% CI: 0.71-0.88], p < 0.001) or other types (HR: 0.60 [95% CI: 0.37-0.98], p = 0.04) among patients who received surgery. PBT was also associated with improved OS compared to photon RT in patients diagnosed with astrocytoma (HR: O.44 [95% CI: 0.39-0.50], p < 0.001), glioblastoma (HR: 0.81 [95% CI: 0.73-0.90], p < 0.001) or other types (HR: 0.41 [95% CI: 0.28-0.60], p < 0.001) among those who did not receive surgery. CONCLUSIONS: Patients who received PBT had longer OS compared to patients who received photon RT (HR:0.67 [95% CI: 0.64-0.71], p < 0.001). In the subset analyses stratified by surgery, the use of PBT was associated with improved OS compared to photon RT in patients who received surgery (HR:0.76 [95% CI: 0.70-0.82], p < 0.001) and in patients who did not receive surgery (HR: 0.61 [95% CI: 0.57-0.65], p < 0.001).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。